Arcellx, Inc. (ACLX)

64.87 -1.40 (-2.11%) USD  |  NASDAQ  |  Jan 12, 16:00
64.80 -0.07 (-0.11%) After-Hours: 20:00
More

Arcellx Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for ACLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Johnson & Johnson Upgrade
Amicus Therapeutics, Inc. Upgrade
Relmada Therapeutics, Inc. Upgrade
Invivyd, Inc. Upgrade